companydata.dkOLANDER CLINICAL CONSULTING K/S: Financial statements 2024
CVR: 35860177
OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,004,138 and a net result of DKK 2,004,688 compared with DKK 1,883,012 the year before. That is an increase of 6.4% compared with the year before. Equity amounted to DKK 554,591. The solvency ratio was 55.1%. The company had 1 employee in the financial year.
- Gross Profit
- 2,004,138 kr.
- Profit/Loss
- 2,004,688 kr.
- Equity
- 554,591 kr.
- Total Assets
- 1,006,977 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2 mio. | 2 mio. | 555 t. | 1 |
| 2023 | - | 1.9 mio. | 1.9 mio. | 622 t. | 0 |
| 2022 | - | 1.9 mio. | 1.9 mio. | 621 t. | - |
| 2021 | - | 1.8 mio. | 1.8 mio. | 687 t. | - |
| 2020 | - | 1.5 mio. | 1.5 mio. | 461 t. | - |
How creditworthy is OLANDER CLINICAL CONSULTING K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
OLANDER CLINICAL CONSULTING K/S has published its annual report for 2023. Gross profit came to DKK 1,882,763, and the net result was DKK 1,883,012.
About OLANDER CLINICAL CONSULTING K/S
OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.